The global IVD Infectious Diseases market was valued at US$ 16620 million in 2023 and is anticipated to reach US$ 22230 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.

IVD Infectious Diseases Market

In Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to help detect infection, Diagnose a medical condition and Prevent disease.

North American market for IVD Infectious Diseases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for IVD Infectious Diseases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for IVD Infectious Diseases in Clinical Laboratories is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of IVD Infectious Diseases include BD, BioMerieux, Abbott, Quidel, Gen-Probe, Abbott, Danaher, Sysmex and Orasure, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for IVD Infectious Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IVD Infectious Diseases.

Report Scope

The IVD Infectious Diseases market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global IVD Infectious Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the IVD Infectious Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of IVD Infectious Diseases Market Report

Report Metric	Details
Report Name	IVD Infectious Diseases Market
Accounted market size in 2023	US$ 16620 million
Forecasted market size in 2030	US$ 22230 million
CAGR	3.8%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Immunochemistry Molecular Diagnostics
Segment by Application	Clinical Laboratories Diagnostic Centers
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	BD, BioMerieux, Abbott, Quidel, Gen-Probe, Danaher, Sysmex, Orasure, Hologic, Cepheid, Qiagen, Roche Diagnostics, Siemens Healthcare, Bio-Rad Laboratories
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of IVD Infectious Diseases companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is IVD Infectious Diseases Market growing?

Ans: The IVD Infectious Diseases Market witnessing a CAGR of 3.8% during the forecast period 2024-2030.

What is the IVD Infectious Diseases Market size in 2030?

Ans: The IVD Infectious Diseases Market size in 2030 will be US$ 22230 million.

Who are the main players in the IVD Infectious Diseases Market report?

Ans: The main players in the IVD Infectious Diseases Market are BD, BioMerieux, Abbott, Quidel, Gen-Probe, Danaher, Sysmex, Orasure, Hologic, Cepheid, Qiagen, Roche Diagnostics, Siemens Healthcare, Bio-Rad Laboratories

What are the Application segmentation covered in the IVD Infectious Diseases Market report?

Ans: The Applications covered in the IVD Infectious Diseases Market report are Clinical Laboratories, Diagnostic Centers

What are the Type segmentation covered in the IVD Infectious Diseases Market report?

Ans: The Types covered in the IVD Infectious Diseases Market report are Immunochemistry, Molecular Diagnostics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global IVD Infectious Diseases Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Immunochemistry

1.2.3 Molecular Diagnostics

1.3 Market by Application

1.3.1 Global IVD Infectious Diseases Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Clinical Laboratories

1.3.3 Diagnostic Centers

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global IVD Infectious Diseases Market Perspective (2019-2030)

2.2 IVD Infectious Diseases Growth Trends by Region

2.2.1 Global IVD Infectious Diseases Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 IVD Infectious Diseases Historic Market Size by Region (2019-2024)

2.2.3 IVD Infectious Diseases Forecasted Market Size by Region (2025-2030)

2.3 IVD Infectious Diseases Market Dynamics

2.3.1 IVD Infectious Diseases Industry Trends

2.3.2 IVD Infectious Diseases Market Drivers

2.3.3 IVD Infectious Diseases Market Challenges

2.3.4 IVD Infectious Diseases Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top IVD Infectious Diseases Players by Revenue

3.1.1 Global Top IVD Infectious Diseases Players by Revenue (2019-2024)

3.1.2 Global IVD Infectious Diseases Revenue Market Share by Players (2019-2024)

3.2 Global IVD Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by IVD Infectious Diseases Revenue

3.4 Global IVD Infectious Diseases Market Concentration Ratio

3.4.1 Global IVD Infectious Diseases Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by IVD Infectious Diseases Revenue in 2023

3.5 IVD Infectious Diseases Key Players Head office and Area Served

3.6 Key Players IVD Infectious Diseases Product Solution and Service

3.7 Date of Enter into IVD Infectious Diseases Market

3.8 Mergers & Acquisitions, Expansion Plans

4 IVD Infectious Diseases Breakdown Data by Type

4.1 Global IVD Infectious Diseases Historic Market Size by Type (2019-2024)

4.2 Global IVD Infectious Diseases Forecasted Market Size by Type (2025-2030)

5 IVD Infectious Diseases Breakdown Data by Application

5.1 Global IVD Infectious Diseases Historic Market Size by Application (2019-2024)

5.2 Global IVD Infectious Diseases Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America IVD Infectious Diseases Market Size (2019-2030)

6.2 North America IVD Infectious Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America IVD Infectious Diseases Market Size by Country (2019-2024)

6.4 North America IVD Infectious Diseases Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe IVD Infectious Diseases Market Size (2019-2030)

7.2 Europe IVD Infectious Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe IVD Infectious Diseases Market Size by Country (2019-2024)

7.4 Europe IVD Infectious Diseases Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific IVD Infectious Diseases Market Size (2019-2030)

8.2 Asia-Pacific IVD Infectious Diseases Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific IVD Infectious Diseases Market Size by Region (2019-2024)

8.4 Asia-Pacific IVD Infectious Diseases Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America IVD Infectious Diseases Market Size (2019-2030)

9.2 Latin America IVD Infectious Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America IVD Infectious Diseases Market Size by Country (2019-2024)

9.4 Latin America IVD Infectious Diseases Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa IVD Infectious Diseases Market Size (2019-2030)

10.2 Middle East & Africa IVD Infectious Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa IVD Infectious Diseases Market Size by Country (2019-2024)

10.4 Middle East & Africa IVD Infectious Diseases Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 BD

11.1.1 BD Company Detail

11.1.2 BD Business Overview

11.1.3 BD IVD Infectious Diseases Introduction

11.1.4 BD Revenue in IVD Infectious Diseases Business (2019-2024)

11.1.5 BD Recent Development

11.2 BioMerieux

11.2.1 BioMerieux Company Detail

11.2.2 BioMerieux Business Overview

11.2.3 BioMerieux IVD Infectious Diseases Introduction

11.2.4 BioMerieux Revenue in IVD Infectious Diseases Business (2019-2024)

11.2.5 BioMerieux Recent Development

11.3 Abbott

11.3.1 Abbott Company Detail

11.3.2 Abbott Business Overview

11.3.3 Abbott IVD Infectious Diseases Introduction

11.3.4 Abbott Revenue in IVD Infectious Diseases Business (2019-2024)

11.3.5 Abbott Recent Development

11.4 Quidel

11.4.1 Quidel Company Detail

11.4.2 Quidel Business Overview

11.4.3 Quidel IVD Infectious Diseases Introduction

11.4.4 Quidel Revenue in IVD Infectious Diseases Business (2019-2024)

11.4.5 Quidel Recent Development

11.5 Gen-Probe

11.5.1 Gen-Probe Company Detail

11.5.2 Gen-Probe Business Overview

11.5.3 Gen-Probe IVD Infectious Diseases Introduction

11.5.4 Gen-Probe Revenue in IVD Infectious Diseases Business (2019-2024)

11.5.5 Gen-Probe Recent Development

11.6 Abbott

11.6.1 Abbott Company Detail

11.6.2 Abbott Business Overview

11.6.3 Abbott IVD Infectious Diseases Introduction

11.6.4 Abbott Revenue in IVD Infectious Diseases Business (2019-2024)

11.6.5 Abbott Recent Development

11.7 Danaher

11.7.1 Danaher Company Detail

11.7.2 Danaher Business Overview

11.7.3 Danaher IVD Infectious Diseases Introduction

11.7.4 Danaher Revenue in IVD Infectious Diseases Business (2019-2024)

11.7.5 Danaher Recent Development

11.8 Sysmex

11.8.1 Sysmex Company Detail

11.8.2 Sysmex Business Overview

11.8.3 Sysmex IVD Infectious Diseases Introduction

11.8.4 Sysmex Revenue in IVD Infectious Diseases Business (2019-2024)

11.8.5 Sysmex Recent Development

11.9 Orasure

11.9.1 Orasure Company Detail

11.9.2 Orasure Business Overview

11.9.3 Orasure IVD Infectious Diseases Introduction

11.9.4 Orasure Revenue in IVD Infectious Diseases Business (2019-2024)

11.9.5 Orasure Recent Development

11.10 Hologic

11.10.1 Hologic Company Detail

11.10.2 Hologic Business Overview

11.10.3 Hologic IVD Infectious Diseases Introduction

11.10.4 Hologic Revenue in IVD Infectious Diseases Business (2019-2024)

11.10.5 Hologic Recent Development

11.11 Cepheid

11.11.1 Cepheid Company Detail

11.11.2 Cepheid Business Overview

11.11.3 Cepheid IVD Infectious Diseases Introduction

11.11.4 Cepheid Revenue in IVD Infectious Diseases Business (2019-2024)

11.11.5 Cepheid Recent Development

11.12 Qiagen

11.12.1 Qiagen Company Detail

11.12.2 Qiagen Business Overview

11.12.3 Qiagen IVD Infectious Diseases Introduction

11.12.4 Qiagen Revenue in IVD Infectious Diseases Business (2019-2024)

11.12.5 Qiagen Recent Development

11.13 Roche Diagnostics

11.13.1 Roche Diagnostics Company Detail

11.13.2 Roche Diagnostics Business Overview

11.13.3 Roche Diagnostics IVD Infectious Diseases Introduction

11.13.4 Roche Diagnostics Revenue in IVD Infectious Diseases Business (2019-2024)

11.13.5 Roche Diagnostics Recent Development

11.14 Siemens Healthcare

11.14.1 Siemens Healthcare Company Detail

11.14.2 Siemens Healthcare Business Overview

11.14.3 Siemens Healthcare IVD Infectious Diseases Introduction

11.14.4 Siemens Healthcare Revenue in IVD Infectious Diseases Business (2019-2024)

11.14.5 Siemens Healthcare Recent Development

11.15 Bio-Rad Laboratories

11.15.1 Bio-Rad Laboratories Company Detail

11.15.2 Bio-Rad Laboratories Business Overview

11.15.3 Bio-Rad Laboratories IVD Infectious Diseases Introduction

11.15.4 Bio-Rad Laboratories Revenue in IVD Infectious Diseases Business (2019-2024)

11.15.5 Bio-Rad Laboratories Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global IVD Infectious Diseases Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Immunochemistry

Table 3. Key Players of Molecular Diagnostics

Table 4. Global IVD Infectious Diseases Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global IVD Infectious Diseases Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global IVD Infectious Diseases Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global IVD Infectious Diseases Market Share by Region (2019-2024)

Table 8. Global IVD Infectious Diseases Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global IVD Infectious Diseases Market Share by Region (2025-2030)

Table 10. IVD Infectious Diseases Market Trends

Table 11. IVD Infectious Diseases Market Drivers

Table 12. IVD Infectious Diseases Market Challenges

Table 13. IVD Infectious Diseases Market Restraints

Table 14. Global IVD Infectious Diseases Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global IVD Infectious Diseases Market Share by Players (2019-2024)

Table 16. Global Top IVD Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Infectious Diseases as of 2023)

Table 17. Ranking of Global Top IVD Infectious Diseases Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by IVD Infectious Diseases Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players IVD Infectious Diseases Product Solution and Service

Table 21. Date of Enter into IVD Infectious Diseases Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global IVD Infectious Diseases Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global IVD Infectious Diseases Revenue Market Share by Type (2019-2024)

Table 25. Global IVD Infectious Diseases Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global IVD Infectious Diseases Revenue Market Share by Type (2025-2030)

Table 27. Global IVD Infectious Diseases Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global IVD Infectious Diseases Revenue Market Share by Application (2019-2024)

Table 29. Global IVD Infectious Diseases Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global IVD Infectious Diseases Revenue Market Share by Application (2025-2030)

Table 31. North America IVD Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America IVD Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America IVD Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe IVD Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe IVD Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe IVD Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific IVD Infectious Diseases Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific IVD Infectious Diseases Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific IVD Infectious Diseases Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America IVD Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America IVD Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America IVD Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa IVD Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa IVD Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa IVD Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)

Table 46. BD Company Detail

Table 47. BD Business Overview

Table 48. BD IVD Infectious Diseases Product

Table 49. BD Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 50. BD Recent Development

Table 51. BioMerieux Company Detail

Table 52. BioMerieux Business Overview

Table 53. BioMerieux IVD Infectious Diseases Product

Table 54. BioMerieux Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 55. BioMerieux Recent Development

Table 56. Abbott Company Detail

Table 57. Abbott Business Overview

Table 58. Abbott IVD Infectious Diseases Product

Table 59. Abbott Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 60. Abbott Recent Development

Table 61. Quidel Company Detail

Table 62. Quidel Business Overview

Table 63. Quidel IVD Infectious Diseases Product

Table 64. Quidel Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 65. Quidel Recent Development

Table 66. Gen-Probe Company Detail

Table 67. Gen-Probe Business Overview

Table 68. Gen-Probe IVD Infectious Diseases Product

Table 69. Gen-Probe Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 70. Gen-Probe Recent Development

Table 71. Abbott Company Detail

Table 72. Abbott Business Overview

Table 73. Abbott IVD Infectious Diseases Product

Table 74. Abbott Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 75. Abbott Recent Development

Table 76. Danaher Company Detail

Table 77. Danaher Business Overview

Table 78. Danaher IVD Infectious Diseases Product

Table 79. Danaher Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 80. Danaher Recent Development

Table 81. Sysmex Company Detail

Table 82. Sysmex Business Overview

Table 83. Sysmex IVD Infectious Diseases Product

Table 84. Sysmex Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 85. Sysmex Recent Development

Table 86. Orasure Company Detail

Table 87. Orasure Business Overview

Table 88. Orasure IVD Infectious Diseases Product

Table 89. Orasure Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 90. Orasure Recent Development

Table 91. Hologic Company Detail

Table 92. Hologic Business Overview

Table 93. Hologic IVD Infectious Diseases Product

Table 94. Hologic Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 95. Hologic Recent Development

Table 96. Cepheid Company Detail

Table 97. Cepheid Business Overview

Table 98. Cepheid IVD Infectious Diseases Product

Table 99. Cepheid Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 100. Cepheid Recent Development

Table 101. Qiagen Company Detail

Table 102. Qiagen Business Overview

Table 103. Qiagen IVD Infectious Diseases Product

Table 104. Qiagen Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 105. Qiagen Recent Development

Table 106. Roche Diagnostics Company Detail

Table 107. Roche Diagnostics Business Overview

Table 108. Roche Diagnostics IVD Infectious Diseases Product

Table 109. Roche Diagnostics Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 110. Roche Diagnostics Recent Development

Table 111. Siemens Healthcare Company Detail

Table 112. Siemens Healthcare Business Overview

Table 113. Siemens Healthcare IVD Infectious Diseases Product

Table 114. Siemens Healthcare Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 115. Siemens Healthcare Recent Development

Table 116. Bio-Rad Laboratories Company Detail

Table 117. Bio-Rad Laboratories Business Overview

Table 118. Bio-Rad Laboratories IVD Infectious Diseases Product

Table 119. Bio-Rad Laboratories Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)

Table 120. Bio-Rad Laboratories Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Global IVD Infectious Diseases Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global IVD Infectious Diseases Market Share by Type: 2023 VS 2030

Figure 3. Immunochemistry Features

Figure 4. Molecular Diagnostics Features

Figure 5. Global IVD Infectious Diseases Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global IVD Infectious Diseases Market Share by Application: 2023 VS 2030

Figure 7. Clinical Laboratories Case Studies

Figure 8. Diagnostic Centers Case Studies

Figure 9. IVD Infectious Diseases Report Years Considered

Figure 10. Global IVD Infectious Diseases Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 11. Global IVD Infectious Diseases Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global IVD Infectious Diseases Market Share by Region: 2023 VS 2030

Figure 13. Global IVD Infectious Diseases Market Share by Players in 2023

Figure 14. Global Top IVD Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Infectious Diseases as of 2023)

Figure 15. The Top 10 and 5 Players Market Share by IVD Infectious Diseases Revenue in 2023

Figure 16. North America IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 17. North America IVD Infectious Diseases Market Share by Country (2019-2030)

Figure 18. United States IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. Canada IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Europe IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe IVD Infectious Diseases Market Share by Country (2019-2030)

Figure 22. Germany IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. France IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. U.K. IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Italy IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Russia IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Nordic Countries IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Asia-Pacific IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific IVD Infectious Diseases Market Share by Region (2019-2030)

Figure 30. China IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Japan IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. South Korea IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Southeast Asia IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. India IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Australia IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Latin America IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America IVD Infectious Diseases Market Share by Country (2019-2030)

Figure 38. Mexico IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Brazil IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa IVD Infectious Diseases Market Share by Country (2019-2030)

Figure 42. Turkey IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Saudi Arabia IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. BD Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 45. BioMerieux Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 46. Abbott Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 47. Quidel Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 48. Gen-Probe Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 49. Abbott Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 50. Danaher Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 51. Sysmex Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 52. Orasure Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 53. Hologic Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 54. Cepheid Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 55. Qiagen Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 56. Roche Diagnostics Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 57. Siemens Healthcare Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 58. Bio-Rad Laboratories Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions